Save time and get answers to complex questions with AI chat
Tenofovir generic patent?How long have hydroxyzine pamoate been on the market?Mobic injection patent oehringer ingelheim france?Patent tenofovir alafenamide gilead?Testosterone enanthate expiration?
See the DrugPatentWatch profile for Alirocumab
Prices vary a lot by country, payer, and dosing schedule. Here’s a typical reference for the United States: - List price (annual): about $14,000–$15,000 per year for alirocumab (Praluent). - Per-injection cost: about $540 per 150 mg dose when used every two weeks (since 26 injections/year ≈ $14k total). - Monthly dosing (300 mg per month, usually given as two 150 mg injections): still about $14k per year, which works out to roughly $1,100 per month (two injections per month). Out-of-pocket costs depend on your insurance, discounts, and patient-assistance programs. Some people pay little or nothing with good coverage; others pay more if they’re under a high-deductible plan. Prices outside the U.S. vary widely, often lower or governed by national pricing. If you’d like, tell me your country and your dosing plan (every 2 weeks vs. monthly), and I can give a more tailored estimate and point you to price-check resources and potential assistance programs.
Other Questions About Alirocumab :